Back to Search Start Over

FoxO6 integrates insulin signaling with gluconeogenesis in the liver

Authors :
Kim, Dae Hyun
Perdomo, German
Zhang, Ting
Slusher, Sandra
Lee, Sojin
Phillips, Brett E.
Fan, Yong
Giannoukakis, Nick
Gramignoli, Roberto
Strom, Stephen
Ringquist, Steven
Dong, H. Henry
Source :
Diabetes. November 1, 2011, Vol. 60 Issue 11, p2763, 12 p.
Publication Year :
2011

Abstract

OBJECTIVE--Excessive endogenous glucose production contributes to fasting hyperglycemia in diabetes. This effect stems from inept insulin suppression of hepatic gluconeogenesis. To understand the underlying mechanisms, we studied the ability of forkhead box 06 (FoxO6) to mediate insulin action on hepatic gluconeogenesis and its contribution to glucose metabolism. RESEARCH DESIGN AND METHODS--We characterized FoxO6 in glucose metabolism in cultured hepatocytes and in rodent models of dietary obesity, insulin resistance, or insulin-deficient diabetes. We determined the effect of FoxO6 on hepatic gluconeogenesis in genetically modified mice with FoxO6 gain-versus loss-of-function and in diabetic db/db mice with selective FoxO6 ablation in the liver. RESULTS--FoxO6 integrates insulin signaling to hepatic gluconeogenesis. In mice, elevated FoxO6 activity in the liver augments gluconeogenesis, raising fasting blood glucose levels, and hepatic FoxO6 depletion suppresses gluconeogenesis, resulting in fasting hypoglycemia. FoxO6 stimulates gluconeogenesis, which is counteracted by insulin. Insulin inhibits FoxO6 activity via a distinct mechanism by inducing its phosphorylation and disabling its transcriptional activity, without altering its subcellular distribution in hepatocytes. FoxO6 becomes deregulated in the insulin-resistant liver, accounting for its unbridled activity in promoting gluconeogenesis and correlating with the pathogenesis of fasting hyperglycemia in diabetes. These metabolic abnormalities, along with fasting hyperglycemia, are reversible by selective inhibition of hepatic FoxO6 activity in diabetic mice. CONCLUSIONS--Our data uncover a FoxO6-dependent pathway by which the liver orchestrates insulin regulation of gluconeogenesis, providing the proof-of-concept that selective FoxO6 inhibition is beneficial for curbing excessive hepatic glucose production and improving glycemic control in diabetes. Diabetes 60:2763-2774, 2011<br />Gluconeogenesis is a life-sustaining process for maintaining blood glucose levels within the physiologic range and providing the sole fuel source for the brain, testes, and erythrocytes during starvation. Gluconeogenesis takes [...]

Details

Language :
English
ISSN :
00121797
Volume :
60
Issue :
11
Database :
Gale General OneFile
Journal :
Diabetes
Publication Type :
Periodical
Accession number :
edsgcl.273194499
Full Text :
https://doi.org/10.2337/db11-0548